Filing Flows › Boston Scientific (BSX) › Gross margin
Boston Scientific (BSX) gross margin by quarter
Boston Scientific's gross margin was 66.7% in Q3 2026 (third quarter 2026), -4.0 pts from Q2 2026. Over the last 7 quarters it ranged from 66.7% (Q3 2026) to 70.7% (Q2 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 66.7% | -4.0 pts | -3.2 pts |
| Q2 2026 | 70.7% | +1.2 pts | +3.1 pts |
| Q1 2026 | 69.5% | -0.1 pts | +0.6 pts |
| Q4 2025 | 69.6% | -0.3 pts | — |
| Q3 2025 | 69.9% | +2.3 pts | — |
| Q2 2025 | 67.7% | -1.2 pts | — |
| Q1 2025 | 68.8% | — | — |
Q3 2026 at a glance
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Boston Scientific's gross margin?
Boston Scientific's gross margin was 66.7% in Q3 2026 (third quarter 2026), -4.0 pts from Q2 2026.
How has Boston Scientific's gross margin changed?
Over the last 7 quarters it ranged from 66.7% (Q3 2026) to 70.7% (Q2 2026).